Fujifilm Sonosite Launches Sonosite LX Premium Point-of-Care Ultrasound System

By MedImaging International staff writers
Posted on 17 Feb 2022

Image: Sonosite LX (Photo courtesy of FUJIFILM Sonosite, Inc.)

FUJIFILM Sonosite, Inc. (Bothell, WA, USA) has added to its next-generation POCUS portfolio with the launch of its new, premium Sonosite LX system, featuring the company’s largest clinical image and a monitor that extends, rotates and tilts to enable enhanced, real-time provider collaboration.

Sonosite LX has a large, adaptable 21.3-inch clinical display that extends, rotates and tilts to accommodate the varied clinical environments at the bedside. The system’s small footprint and adjustable display foster collaboration, allowing for real-time image and information sharing with the patient, other clinicians, residents and other hospital staff. The system was engineered to include primary and secondary study controls on the clinical touchscreen display – including quick access to the most-used optimizations such as depth, gain, and measurements - to deliver an optimized heads-up workflow for clinicians. The Sonosite LX is compatible with the redesigned family of transducers launched with Sonosite PX that have dedicated exam types for study-specific imaging and workflow optimization.

Designed to be used with the Sonosite LX and Sonosite PX, the company has also launched a new T8-3 transesophageal transducer and Cardiac Resuscitation exam type, to assist clinicians in using transesophageal ultrasound (TEU) at the point of care. The T8-3 transducer enables clinicians to provide TEU at the point of care by enabling repeatable cardiac imaging regardless of patient condition or body habitus; providing a lightweight handle and flexible shaft for easy manipulation and a small tip for ease of insertion; enabling low power consumption to maintain temperature while monitoring over time; and delivering FUJIFILM Sonosite’s most advanced image clarity. The Sonosite LX, T8-3 Transducer, and Cardiac Resuscitation exam type are now commercially available in the US, Australia and New Zealand, with plans to launch in Canada, Europe, China and Japan in the future.

“Sonosite LX was inspired by and designed with clinician partners, focusing on the evolving ways ultrasound can support the quadruple aim at the point of care, wherever that may be,” said Rich Fabian, president and COO, FUJIFILM Sonosite. “This launch reflects an ongoing commitment to delivering leading edge technology for clinicians and their patients, technology that’s backed up by a world-class ecosystem of services, support and education.”

Related Links:
FUJIFILM Sonosite, Inc.